We are live on ! Find out more
AG

Aperio Group Portfolio holdings

AUM $33.8B
1-Year Est. Return 31.46%
This Fund
S&P 500
This Quarter Est. Return
+4.26%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.02%
10 Year Est. Return
AUM
$24.5B
AUM Growth
+$1.31B
Cap. Flow
+$569M
Cap. Flow %
2.32%
Top 10 Hldgs %
15.71%
Holding
3,091
New
800
Increased
1,401
Reduced
859
Closed
15

Top Buys

Rank Stock Value
1
T icon
AT&T
T
+$23.2M
2
JNJ icon
Johnson & Johnson
JNJ
+$21M
3
MSFT icon
Microsoft
MSFT
+$20.5M
4
DOW icon
Dow Inc
DOW
+$20.2M
5
JPM icon
JPMorgan Chase
JPM
+$15.1M

Sector Composition

Rank Sector Weight
1 Technology 18.55%
2 Financials 16.83%
3 Healthcare 12.9%
4 Consumer Discretionary 10.27%
5 Communication Services 8.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FTSI
2526
DELISTED
FTS International, Inc. Common Stock
FTSI
$52K ﹤0.01%
+463
New +$76.5K
TUSK icon
2527
Mammoth Energy Services
TUSK
$122M
$51K ﹤0.01%
7,389
-4,834
-40% -$61.4K
WVE icon
2528
Wave Life Sciences
WVE
$1.12B
$51K ﹤0.01%
+1,948
New +$54.6K
PETX
2529
DELISTED
Aratana Therapeutics, Inc.
PETX
$51K ﹤0.01%
+9,895
New +$44.5K
HCM icon
2530
HUTCHMED
HCM
$1.96B
$50K ﹤0.01%
+2,290
New +$65.4K
NGS icon
2531
Natural Gas Services Group
NGS
$457M
$50K ﹤0.01%
+3,023
New +$49.5K
UBX
2532
DELISTED
Unity Biotechnology
UBX
$50K ﹤0.01%
+527
New +$44.8K
MRTX
2533
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$50K ﹤0.01%
+490
New +$38.1K
RRD
2534
DELISTED
RR Donnelley & Sons Co.
RRD
$50K ﹤0.01%
25,269
-3,783
-13% -$12.5K
JMEI
2535
DELISTED
Jumei International Holding Limited American depositary shares, each representing ten Class A ordina
JMEI
$50K ﹤0.01%
2,016
CBIO
2536
Crescent Biopharma
CBIO
$546M
$49K ﹤0.01%
+41
New +$49K
MTSI icon
2537
MACOM Technology Solutions
MTSI
$17.4B
$49K ﹤0.01%
+3,269
New +$49.3K
NIC icon
2538
Nicolet Bankshares
NIC
$3.6B
$49K ﹤0.01%
+787
New +$47.6K
OMER icon
2539
Omeros
OMER
$845M
$49K ﹤0.01%
+3,149
New +$56.5K
PAM icon
2540
Pampa Energía
PAM
$4.57B
$49K ﹤0.01%
+1,423
New +$37.2K
QUOT
2541
DELISTED
Quotient Technology Inc
QUOT
$49K ﹤0.01%
+4,569
New +$46.3K
LCI
2542
DELISTED
Lannett Company, Inc.
LCI
$49K ﹤0.01%
+2,053
New +$54.3K
MGNI icon
2543
Magnite
MGNI
$2.83B
$48K ﹤0.01%
+7,472
New +$45.9K
CLVS
2544
DELISTED
Clovis Oncology, Inc.
CLVS
$48K ﹤0.01%
+3,235
New +$58.5K
FPRX
2545
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$48K ﹤0.01%
7,932
-6,008
-43% -$57.4K
MODN
2546
DELISTED
MODEL N, INC.
MODN
$47K ﹤0.01%
+2,424
New +$44.6K
ATRS
2547
DELISTED
Antares Pharma, Inc.
ATRS
$47K ﹤0.01%
+14,399
New +$41.7K
ATEN icon
2548
A10 Networks
ATEN
$2.07B
$46K ﹤0.01%
+6,769
New +$44.4K
KREF
2549
KKR Real Estate Finance Trust
KREF
$466M
$46K ﹤0.01%
+2,290
New +$46.3K
LX
2550
LexinFintech Holdings
LX
$246M
$46K ﹤0.01%
+4,111
New +$51.2K

Similar funds

Aperio Group's Q2 2019 Portfolio in Review

As of Q2 2019, Aperio Group held 3,091 positions worth $24.5B, up 5.7% from $23.2B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Aperio Group's Q2 2019 filing shows 800 new, 1,401 increased, 859 reduced and 15 closed positions. Its largest new stake was Dow Inc: 383,303 shares worth $18.9M. The largest sale was American National Group, Inc. Common Stock, an estimated $36.1M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • Aperio Group's largest Q2 2019 buy was Dow Inc: 383,303 shares worth $18.9M.
  • Aperio Group added most to AT&T in Q2 2019, an estimated $23.2M increase.
  • Aperio Group's biggest Q2 2019 reduction was American National Group, Inc. Common Stock, cutting an estimated $36.1M.
  • Aperio Group fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $6.06M.
  • Aperio Group's ten largest holdings make up 16% of its $24.5B portfolio in Q2 2019.
  • Aperio Group opened 800 new positions and closed 15 in Q2 2019.
  • Aperio Group's portfolio value rose 5.7% quarter-over-quarter to $24.5B.

Based on Aperio Group's 13F filing for Q2 2019, filed 30 Jul 2019.